Impact Factor
4.18
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.87
4,270 total citations
h5-index
62
h5 depth signal
Cited share
79.7%
743 of 932
Total citations
4,270
Citation footprint
Metric signal
4.91
External metric anchor
Self-citation
2.2%
92 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Italy
811
Germany
672
United Kingdom
509
United States
502
France
502
Citing Fields of Research
Neurodegenerative Disorders
1,193
Neuromuscular Disorders
997
Brain Neurological Disorders
719
Nervous System Disorders
644
Vascular Disorders
614
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,067
Articles tracked across the journal lifetime
Indexed publication set
932
743 cited publications
Last 12 months
400
33.3 publications/month
Open access share
100.0%
400 OA publications in the last year
Leading citing country
Italy
811 citing publications
Leading citing field
Neurodegenerative Disorders
1,193 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v6n1, 1999-
v6n1, 1999-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Neuromuscular Disorders
Nervous System Disorders
Brain Neurological Disorders
Vascular Disorders
Issuing & Sponsoring Bodies
Contributor
European Federation of Neurological Societies
Contributor
European Academy of Neurology
Broad Categories
Neurology
Neuromuscular Disorders
Neurodegenerative Disorders
Vascular Disorders
Brain Neurological Disorders
MeSH Descriptors
Nervous System Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/ene.70793
Open DOI
Nerve Ultrasound Features of Peripheral Nervous System Lymphoma and Non‐Systemic Vasculitic Neuropathy
Objective: To compare the clinical, electrophysiological, and nerve ultrasound characteristics of peripheral nervous system lymphoma (PNSL) and non‐systemic vasculitic neuropathy (NSVN). Methods: Between July 2015 and May 2026, 9 PNSL pa...
02
DOI 10.1111/ene.70787
Open DOI
Transition From Child to Adult Care in Paediatric Neurological Disorders in Europe—A Joint EAN ‐ EPNS Survey of Current Practices for Healthcare Providers
Background: Transition from paediatric to adult care is essential for young people with paediatric‐onset neurological disorders, yet remains inconsistently structured across Europe. This study aimed to characterise current transition pra...
03
DOI 10.1111/ene.70774
Open DOI
Altered Saccades, Blink and Pupil Responses in Functional Motor Disorder: New Insight Into Neurobiological Mechanisms
Background: Functional motor disorder (FMD) is a common and disabling condition with incompletely understood pathophysiology. Eye‐tracking offers a method to objectively examine cognitive and motor control processes and their underlying ...
04
DOI 10.1111/ene.70761
Open DOI
Migraine in Older Adults: Age‐Related Clinical Features From the Italian RICe Registry
Background: Primary headaches, particularly migraine, are prevalent disorders insufficiently characterized in older adults. This multicentre study evaluated headache diagnoses, focusing on migraine, across age groups in headache centers ...
05
DOI 10.1111/ene.70776
Open DOI
Non‐Invasive Intracranial Pressure Waveform Assessment as a Screening Test for Abnormal Lumbar Puncture Results
Background: Lumbar puncture (LP) is essential for detecting intracranial hypertension (IH) but is often non‐diagnostic and not without complications. A skull extensometer‐based non‐invasive intracranial pressure waveform assessment (NIWA...
06
DOI 10.1111/ene.70784
Open DOI
Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder
Objectives: Magnetic resonance imaging (MRI) is widely used to support relapse diagnosis in neuromyelitis optica spectrum disorder (NMOSD), yet some patients present with attack‐like symptoms without corresponding lesions. We assessed se...
07
DOI 10.1111/ene.70775
Open DOI
Science Is a Lot of Fun: How Professor Jes Olesen Made Discoveries in Migraine
08
DOI 10.1111/ene.70771
Open DOI
Anti‐ CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity ( PIRA ) in People With Multiple Sclerosis
Background: Highly effective (HE) disease‐modifying therapies (DMTs) reduce relapse‐associated worsening (RAW) and progression independent of relapse activity (PIRA). Natalizumab (NTZ) and anti‐CD20 agents show similar efficacy on relaps...
09
DOI 10.1111/ene.70779
Open DOI
Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier
Background: Amyloid‐related imaging abnormalities (ARIA) are the most relevant adverse events associated with anti‐amyloid therapies in Alzheimer's disease. Methods: We report a case of progressive ARIA after discontinuation of lecanemab...
10
DOI 10.1111/ene.70782
Open DOI
Transcutaneous Carbon Dioxide Monitoring in Amyotrophic Lateral Sclerosis: A Scoping Review
Background: Respiratory failure is the leading cause of death in amyotrophic lateral sclerosis (ALS). Conventional pulmonary function tests are effort‐dependent and may fail to detect early nocturnal hypoventilation. Transcutaneous carbo...
Bibliographical & Catalog Notes
Title from cover.
Vol. 1 complete in 3 issues.
Also issued online.
Official journal of the European Federation of Neurological Societies, 1994-May 2014; European Academy of Neurology, June 2014- .
(1998)19980622 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper